An evaluation of the polymorphisms Ins16bp and Arg72Pro in p53 as breast cancer risk modifiers in BRCA1 and BRCA2 mutation carriers.

Autor: Osorio, A.1 aosorio@cnio.es, Pollán, M.2, Pita, G.3, Schmutzler, R. K.4, Versmold, B.4, Engel, C.5, Meindl, A.6, Arnold, N.7, Preisler-Adams, S.8, Niederacher, D.9, Hofmann, W.10, Gadzicki, D.11, Jakubowska, A.12, Hamann, U.13, Lubinski, J.12, Toloczko-Grabarek, A.12, Cybulski, C.12, Debniak, T.12, Llort, G.14, Yannoukakos, D.15
Zdroj: British Journal of Cancer. 9/16/2008, Vol. 99 Issue 6, p974-977. 4p. 2 Charts.
Databáze: Academic Search Ultimate